Increased H2O2 level in exhaled breath condensate in primary breast cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 6, 2010, Pages 923-930

  Stolarek, Robert A ^a   Potargowicz, Elrbieta ^a   Sȩklewska, Ewa ^a   Jakubik, Jarosiaw ^a   Lewandowski, Marek ^b   Jeziorski, Arkadiusz ^a   Nowak, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Center for High School Education   (Poland)

Author keywords

Exhaled breath condensate; Hydrogen peroxide; Primary breast cancer

Indexed keywords

ANTIOXIDANT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; FERRIC CITRATE IRON REDUCTASE; FLAVINE MONONUCLEOTIDE REDUCTASE; HYDROGEN PEROXIDE; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AXILLA; BLOOD; BREAST TUMOR; BREATH ANALYSIS; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMA;

ADULT; AGED; ANTIOXIDANTS; AXILLA; BREAST NEOPLASMS; BREATH TESTS; CASE-CONTROL STUDIES; FEMALE; FMN REDUCTASE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PLASMA; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951635218     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-009-0734-x     Document Type: Article

References (35)

1. Adzic M, Niciforovic A, Vucic V, Neskovic-Konstantinovic Z, Spasic SD, Jones DR, Radojcic MB, Spasic MB (2006) Systemic NF-kappaB activation in blood cells of breast cancer patients. Redox Rep 11:39-44
2. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg I, Jaiswal AK, Rosen EM (2004) BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64:7893-7909
3. Balogh N, Gaal T, Ribiczeyne PS, Petri A (2001) Biochemical and antioxidant changes in plasma and erythrocytes of pentathlon horses before and after exercise. Vet Clin Pathol 30:214-218
4. Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 239:70-76
5. Carney WP, Leitzel K, Ali S, Neumann R, Lipton A (2007) HER-2/neu diagnostics in breast cancer. Breast Cancer Res 9:207
6. Dasari A, Bartholomew JN, Volonte D, Galbiati F (2006) Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 22:10805-10814
7. De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CM (2005) Long-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 18:41-47
8. de Cavanagh EM, Honegger AE, Hofer E, Bordenave RH, Bullorsky EO, Chasseing NA, Fraga C (2002) Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients. Cancer 94:3247-3251
9. Degraft-Johnson J, Kolodziejczyk K, Krol M, Nowak P, Krol B, Nowak D (2007) Ferric-reducing ability power of selected plant polyphenols and their metabolites: implications for clinical studies on the antioxidant effects of fruits and vegetable consumption. Basic Clin Pharmacol Toxicol 100:345-352
10. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM (2006) Concordance among gene-expressionbased predictors for breast cancer. N Engl J Med 355:560-569
11. Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M (2006) Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and inWltrative). Cancer Sci 97(10):1044-1049
12. Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-ErnstoV L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M (2007) Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121:483-490
13. Gerristen WB, Asin J, Zanen P, van der Bosch JM, Haas FJ (2005) Markers of inXammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 99:84-90
14. Hietanen E, Bartsch H, Bereziat JC, Camus AM, McClinton S, Eremin O, Davidson L, Boyle P (1994) Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr 48:575-586
15. KasapoviT J, PejiT S, TodoroviT A, StojiljkoviT V, PajoviT SB (2008) Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 26:723-730
16. Korkaya H, Paulson A, Iovino F, Wicha MS (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27:6120-6130
17. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S (2003) Oxidative stress in expired breath condensate of patients with COPD. Chest 124:1373-1380
18. Koutsokera A, Loukides S, Gourgoulianis KI, Kostikas K (2008) Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. Curr Med Chem 15:620-630
19. Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC (2006) Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway. Cancer Lett 259:82-98
20. Loukides S, Bouros D, Papatheodorou G, Panagou P, Siafakas NM (2002) The relationships among hydrogen peroxide in expired breath condensate, airway inXammation, and asthma severity. Chest 121:338-346
21. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R (2006) Targeting tumor associated macrophages as a novel strategy against breast cancer. J Clin Invest 116:2132-2141
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319-338
23. Moore A (2007) Breast-cancer therapy-looking back to the future. N Engl J Med 357:1547-1549
24. Nass SJ, Davidson NE (1999) The biology of breast cancer. Hematol Oncol Clin North Am 13:311-332
25. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P (1999) Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no Significant eVect of cigarette smoking. Respir Med 93:389-396
26. Phillips M, Cataneo RN, DitkoV BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Rahbari-Oskoui F, Wong C (2003) Volatile markers of breast cancer in the breath. Breast J 9:184-191
27. Phillips M, Cataneo RN, DitkoV BA, Fisher P, Greenberg J, Gunawardena R, Kwon CS, Tietje O, Wong C (2006) Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat 99:19-21
28. Rysz J, Kasielski M, Apanasiewicz J, Król M, Wosnicki A, Luciak M, Nowak D (2004) Increased hydrogen peroxide in the exhaled breath of uraemic patients unaVected by haemodialysis. Nephrol Dial Transplant 19:158-163
29. Rysz J, Stolarek RA, Pedzik A, Fijalkowska J, Luczynska M, Sarniak A, Kasielski M, Makowka A, Nowicki M, Nowak D (2007) Increased exhaled H2O2 and impaired lung function in patients undergoing bioincompatible hemodialysis. Int J Artif Organs 30:879-888
30. Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte derived hydrogen peroxide are the underlying mechanism of suppression of T-Cell function in advanced cancer patients. Cancer Res 61:4756-4760
31. Stolarek R, Szkudlarek U, Luczynska M, Kasielski M, Ciesla W, Lewinski A, Nowak D (2008) Decreased H2O2 in exhaled breath condensate during pregnancy-feasible eVect of 17beta-estradiol. Respir Physiol Neurobiol 162:152-159
32. Szkudlarek U, Maria L, Kasielski M, Kaucka S, Nowak D (2003) Exhaled hydrogen peroxide correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects. Respir Med 97:718-725
33. Xu J, Zhou JY, Wu GS (2006) Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res 66:10092-10099
34. Yau C, Benz CC (2008) Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res 10:R61
35. Zhang J, Warren MA, Shoemaker SF, Ip MM (2007) NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB. Endocrinology 148:268-278